Atreca to Present at Two Upcoming Virtual Investor Conferences
September 03, 2020 08:00 ET
|
Atreca, Inc.
SOUTH SAN FRANCISCO, Calif., Sept. 03, 2020 (GLOBE NEWSWIRE) -- Atreca, Inc. (Atreca) (NASDAQ: BCEL), a biotechnology company focused on developing novel therapeutics generated through a unique...
Atreca Reports Second Quarter 2020 Financial Results and Recent Corporate Developments
August 12, 2020 08:30 ET
|
Atreca, Inc.
SOUTH SAN FRANCISCO, Calif., Aug. 12, 2020 (GLOBE NEWSWIRE) -- Atreca, Inc. (Atreca) (NASDAQ: BCEL), a clinical-stage biotechnology company focused on developing novel therapeutics generated through...
Atreca to Present at Two Upcoming Virtual Healthcare Conferences
August 05, 2020 16:30 ET
|
Atreca, Inc.
SOUTH SAN FRANCISCO, Calif., Aug. 05, 2020 (GLOBE NEWSWIRE) -- Atreca, Inc. (Atreca) (NASDAQ: BCEL), a clinical-stage biotechnology company focused on developing novel therapeutics generated through...
Atreca, Inc. Announces Pricing of Underwritten Public Offering of Common Stock
July 16, 2020 00:06 ET
|
Atreca, Inc.
SOUTH SAN FRANCISCO, Calif., July 16, 2020 (GLOBE NEWSWIRE) -- Atreca, Inc. (Nasdaq: BCEL), a biopharmaceutical company utilizing its differentiated platform to discover and develop novel...
Atreca, Inc. Announces Proposed Underwritten Public Offering of Class A Common Stock
July 15, 2020 16:01 ET
|
Atreca, Inc.
REDWOOD CITY, Calif., July 15, 2020 (GLOBE NEWSWIRE) -- Atreca, Inc. (Nasdaq: BCEL), a biopharmaceutical company utilizing its differentiated platform to discover and develop novel antibody-based...
Atreca and Xencor Enter Strategic Collaboration to Discover, Develop and Commercialize Novel T Cell Engaging Bispecific Antibodies
July 08, 2020 08:01 ET
|
Atreca, Inc.
SOUTH SAN FRANCISCO, Calif. and MONROVIA, Calif., July 08, 2020 (GLOBE NEWSWIRE) -- Atreca, Inc. (Atreca) (NASDAQ: BCEL), a clinical-stage biotechnology company focused on developing novel...
Atreca Announces Webinar to Present ATRC-101 Preclinical Data Update on Monday, June 15, 2020
June 11, 2020 08:00 ET
|
Atreca, Inc.
SOUTH SAN FRANCISCO, Calif., June 11, 2020 (GLOBE NEWSWIRE) -- Atreca, Inc. (Atreca) (NASDAQ: BCEL), a clinical-stage biotechnology company focused on developing novel therapeutics generated through...
Atreca Announces Appointment of Kristine M. Ball to its Board of Directors
May 21, 2020 08:00 ET
|
Atreca, Inc.
SOUTH SAN FRANCISCO, Calif., May 21, 2020 (GLOBE NEWSWIRE) -- Atreca, Inc. (Atreca) (NASDAQ: BCEL), a biotechnology company focused on developing novel therapeutics generated through a unique...
Atreca Reports First Quarter 2020 Financial Results and Recent Corporate Developments
May 14, 2020 16:30 ET
|
Atreca, Inc.
SOUTH SAN FRANCISCO, Calif., May 14, 2020 (GLOBE NEWSWIRE) -- Atreca, Inc. (Atreca) (NASDAQ: BCEL), a clinical-stage biotechnology company focused on developing novel therapeutics generated through...
Atreca Announces Poster Presentation at the American Society of Clinical Oncology (ASCO) 2020 Virtual Scientific Program
May 13, 2020 17:00 ET
|
Atreca, Inc.
SOUTH SAN FRANCISCO, Calif., May 13, 2020 (GLOBE NEWSWIRE) -- Atreca, Inc. (Atreca) (NASDAQ: BCEL), a clinical-stage biotechnology company focused on developing novel therapeutics generated through...